| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2022 | BDSX Biodesix Inc | Kennedy Lawrence T. Jr | 10% Owner | Buy | 10,869,565 | $1.15 | $12,499,999.75 | +412.5% | +76.9% | +1.5% | |
| Nov 21, 2022 | TWST Twist Bioscience Corp | Banyai William81 | See Remarks | Sell | 1,275 | $24.90 | $31,747.50 | -0.5% | -19.8% | -7.4% | |
| Nov 21, 2022 | BDSX Biodesix Inc | Watts Charles M | Director | Buy | 43,478 | $1.15 | $49,999.70 | +553.5% | +76.9% | +1.5% | |
| Nov 17, 2022 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 15,000 | $531.46 | $7,971,921.03 | -0.7% | +7.0% | -11.9% | |
| Nov 16, 2022 | NTRA Natera, Inc. | Healy James | Director | Sell | 2,400 | $37.71 | $90,498.00 | -100% | +14.5% | +43.8% | |
| Nov 16, 2022 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 6,775 | $148.19 | $1,003,987.25 | -2.4% | +4.0% | -22.4% | |
| Nov 16, 2022 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 342 | $35.89 | $12,274.59 | - | -8.1% | -23.1% | |
| Nov 16, 2022 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 1,306 | $35.89 | $46,873.12 | -0.3% | -8.1% | -23.1% | |
| Nov 16, 2022 | CRL Charles River Laboratories International, Inc. | Knell Michael Gunnar67 | Csvp&Chief Accounting Officer | Sell | 855 | $248.59 | $212,544.45 | -11.7% | +5.2% | -20.8% | |
| Nov 16, 2022 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 1,796 | $35.89 | $64,459.52 | -0.4% | -8.1% | -23.1% | |
| Nov 16, 2022 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 1,294 | $2.71 | $3,506.74 | -0.6% | +22.1% | -63.3% | |
| Nov 16, 2022 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer | Sell | 1,295 | $2.71 | $3,509.45 | -0.9% | +22.1% | -63.3% | |
| Nov 16, 2022 | PSNL Personalis, Inc. | Moore Stephen Michael52 | General Counsel | Sell | 2,045 | $2.71 | $5,541.95 | -2.2% | +22.1% | -63.3% | |
| Nov 16, 2022 | MEDP Medpace Holdings, Inc. | Brady Kevin M.45 | CFO &Treasurer | Sell | 2,000 | $228.92 | $457,839.76 | -24.0% | -3.6% | +24.9% | |
| Nov 16, 2022 | MTD Mettler Toledo International Inc/ | Filliol Olivier A71 | Director | Sell | 13,300 | $1,406.16 | $18,701,961.19 | -40.6% | +10.7% | -24.8% | |
| Nov 15, 2022 | DHR Danaher Corp /de/ | Couchara Georgeann56 | SVP, Human Resources | Sell | 1,884 | $271.61 | $511,719.29 | -26.0% | -3.9% | -23.0% | |
| Nov 15, 2022 | MEDP Medpace Holdings, Inc. | Geiger Jesse J60 | President | Sell | 7,000 | $230.00 | $1,610,000.00 | -52.3% | +1.0% | +24.6% | |
| Nov 15, 2022 | CRL Charles River Laboratories International, Inc. | Parisotto Shannon M67 | Cevp, Disc &Safety Assessment | Sell | 2,279 | $249.90 | $569,522.10 | -47.7% | +1.4% | -25.0% | |
| Nov 15, 2022 | GH Guardant Health, Inc. | Kalia Kumud61 | Chief Information Officer | Sell | 3,125 | $51.87 | $162,082.19 | -13.4% | -45.7% | -55.5% | |
| Nov 14, 2022 | MTD Mettler Toledo International Inc/ | Finney Elisha W66 | Director | Sell | 225 | $1,484.34 | $333,975.95 | -17.9% | +7.7% | -27.4% | |
| Nov 11, 2022 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 2 | $29.34 | $58.68 | - | -15.7% | -25.9% | |
| Nov 11, 2022 | DHR Danaher Corp /de/ | McGrew Matthew66 | EVP &Chief Financial Officer | Sell | 18,935 | $274.72 | $5,201,845.26 | -24.2% | -5.9% | -27.3% | |
| Nov 11, 2022 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 6,000 | $30.23 | $181,356.96 | -5.4% | -15.7% | -25.9% | |
| Nov 11, 2022 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $526.57 | $10,531,400.49 | -0.5% | +5.7% | -16.7% | |
| Nov 10, 2022 | DHR Danaher Corp /de/ | Honeycutt Jennifer73 | Executive Vice President | Sell | 8,211 | $265.00 | $2,175,915.00 | -53.4% | -2.2% | -26.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.